Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,628 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,359 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07814365 | PBI for Low-risk Breast Cancer | withdrawn | N/A | 0 | Fudan UniversityOTHER | 1 | Sep 16, 2026 | clinicaltrials |
| NCT03804255 | Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting | withdrawn | — | 0 | ECOG-ACRIN Cancer Research GroupNETWORK | 1 | Sep 15, 2026 | clinicaltrials |
| NCT07805538 |
| Response-Adapted Omission of Nodal Boost In N3 Breast Cancer After Neoadjuvant Therapy |
| withdrawn |
| N/A |
| 0 |
| Fudan UniversityOTHER |
| 1 |
| Sep 15, 2026 |
| clinicaltrials |
| NCT06982222 | Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | Aug 28, 2026 | clinicaltrials |
| NCT06052345 | Paclitaxel-induced Polyneuropathy in Breast Cancer: Early Detection, Risk Factors, Quality of Life and Lifestyle Outcomes(CIPN-REBECCA) | withdrawn | — | 0 | Theodoros FoukakisOTHER | 1 | Aug 14, 2026 | clinicaltrials |
| NCT06610097 | TNBC Gut Microbiota During Neoadjuvant Treatment | withdrawn | N/A | 0 | Scripps HealthOTHER | 1 | Aug 12, 2026 | clinicaltrials |
| NCT04364672 | Molecular Neuroimaging to Assess the Link Between Neuroinflammation and Cognitive Impairment in Breast Cancer | withdrawn | Phase 1 | 0 | University of Alabama at BirminghamOTHER | 0 | Jul 27, 2026 | clinicaltrials |
| NCT04348643 | Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Jul 10, 2026 | clinicaltrials |
| NCT03946423 | BAriaTric Surgery After Breast Cancer Treatment (BATS) | withdrawn | N/A | 0 | Masonic Cancer Center, University of MinnesotaOTHER | 0 | Jul 9, 2026 | clinicaltrials |
| NCT07693374 | Chinese Medicinal Component Relieves CIPN and Mitochondria Function | withdrawn | N/A | 0 | Taiwan Municipal An-Nan Hospital-China Medical UniversityOTHER | 1 | Jul 9, 2026 | clinicaltrials |
| NCT04273555 | Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging | withdrawn | Phase 1 / Phase 2 | 0 | University of Alabama at BirminghamOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT07136493 | Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT04016818 | Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution | withdrawn | Early Phase 1 | 0 | Stanford UniversityOTHER | 1 | May 29, 2026 | clinicaltrials |
| NCT07134556 | Phase II Trial Evaluating the Safety and Efficacy of the Combination of Zimberelimab, Domvanalimab and Sacituzumab Govitecan as 1L Therapy for PD-L1 Positive Advanced TNBC(ADJUNCT) | withdrawn | Phase 2 | 0 | MedSIROTHER | 0 | May 1, 2026 | clinicaltrials |
| NCT02856503 | Effect of High Dose Vitamin D on Cancer Biomarkers and Breast Cancer Tumors | withdrawn | Phase 1 / Phase 2 | 0 | Eli Avisar, MDOTHER | 0 | Apr 17, 2026 | clinicaltrials |
| NCT06229392 | A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer | withdrawn | Phase 1 | 0 | Rush University Medical CenterOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT03868475 | Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast Lesions(VAPEX) | withdrawn | N/A | 0 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 0 | Mar 9, 2026 | clinicaltrials |
| NCT07439432 | Stereotactic Guided Biopsy and Cryoablation | withdrawn | N/A | 0 | Montefiore Medical CenterOTHER | 0 | Feb 27, 2026 | clinicaltrials |
| NCT05014295 | Patient Recall of Cancer Screening and Diagnosis | withdrawn | N/A | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Feb 24, 2026 | clinicaltrials |
| NCT06585969 | A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer(DISCORDANT) | withdrawn | Phase 3 | 0 | Danish Breast Cancer Cooperative GroupOTHER | 0 | Feb 12, 2026 | clinicaltrials |
| NCT07226102 | Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast Cancer | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT06613516 | Effect of Capivasertib on ctDNA in ER Positive Breast Cancer(CaptAin) | withdrawn | Phase 2 | 0 | Imperial College LondonOTHER | 1 | Dec 24, 2025 | clinicaltrials |
| NCT05957042 | Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI). | withdrawn | Early Phase 1 | 0 | Milton S. Hershey Medical CenterOTHER | 1 | Dec 10, 2025 | clinicaltrials |
| NCT04188119 | A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer(IMpALA) | withdrawn | Phase 2 | 0 | The Christie NHS Foundation TrustOTHER | 0 | Dec 8, 2025 | clinicaltrials |
| NCT07150767 | A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) Combined With Neoadjuvant Treatment for Locally Advanced Breast Cancer | withdrawn | Phase 1 | 0 | Beijing Bio-Targeting Therapeutics Technology Co., LtdINDUSTRY | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07092475 | The Impact of Intraoperative Methadone on Postoperative Opioid Use | withdrawn | Phase 3 | 0 | University of UtahOTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT05634954 | Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer | withdrawn | Phase 1 | 0 | GE HealthcareINDUSTRY | 1 | Oct 23, 2025 | clinicaltrials |
| NCT04419181 | Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer | withdrawn | Phase 2 | 0 | University of RochesterOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT04794816 | What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 14, 2025 | clinicaltrials |
| NCT03974204 | Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis. | withdrawn | N/A | 0 | Centre Oscar LambretOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT06597773 | Online Patient Navigation Program for Patients With Breast Cancer | withdrawn | N/A | 0 | Medicos e Investigadores en la Lucha contra el Cancer de MamaOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT06672224 | Indocyanine Green Fluoroscopy and SPY Angiography for the Assessment of Lymphatic Structure in Breast Cancer Patients at Risk for Breast Cancer-Related Lymphedema | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 0 | Sep 17, 2025 | clinicaltrials |
| NCT00466830 | Psychological and Social Factors and Risk Chronic Pain After Surgery in Women With Breast Cancer(SDPM) | withdrawn | — | — | Institut BergoniéOTHER | 0 | Sep 11, 2025 | clinicaltrials |
| NCT00210145 | Socio-aesthetic Intervention on Body Image and Quality of Life in Women With Breast Cancer.(ASE K SEIN) | withdrawn | — | 0 | Institut BergoniéOTHER | 1 | Sep 4, 2025 | clinicaltrials |
| NCT06084689 | Targeting MDMD and PD1 in Tumors With Tertiary Lymphoid Structures(EMPIRE) | withdrawn | Phase 2 | 0 | Institut BergoniéOTHER | 1 | Sep 2, 2025 | clinicaltrials |
| NCT04756765 | Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer | withdrawn | Phase 2 | 0 | Stanford UniversityOTHER | 1 | Aug 17, 2025 | clinicaltrials |
| NCT05678205 | A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors | withdrawn | Phase 1 / Phase 2 | 0 | Artiva Biotherapeutics, Inc.INDUSTRY | 2 | Jul 30, 2025 | clinicaltrials |
| NCT06246786 | Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer) | withdrawn | Early Phase 1 | 0 | Virginia G. KaklamaniOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT06590558 | Testing the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast Cancer | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | Jul 3, 2025 | clinicaltrials |
| NCT06852560 | A Trial Assessing Feasibility of Allostatic Load Biomarkers and CVD Risk Among Black Breast Cancer Survivors(GEM) | withdrawn | N/A | 0 | University of FloridaOTHER | 0 | Jun 26, 2025 | clinicaltrials |
| NCT03941223 | Regional Anesthesia for Breast Surgery | withdrawn | N/A | 0 | Azienda USL Reggio Emilia - IRCCSOTHER_GOV | 1 | Jun 25, 2025 | clinicaltrials |
| NCT06494046 | Defining Musical Toxicity and Its Effect on Patient Well-being | withdrawn | — | 0 | Mayo ClinicOTHER | 1 | Jun 4, 2025 | clinicaltrials |
| NCT05990478 | A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer | withdrawn | — | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 0 | May 21, 2025 | clinicaltrials |
| NCT06145399 | A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer | withdrawn | Early Phase 1 | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 0 | May 18, 2025 | clinicaltrials |
| NCT06978478 | An Imaging Study in ER Negative Breast Cancer by Targeting αvβ6(IMETAB6) | withdrawn | N/A | 0 | Queen Mary University of LondonOTHER | 1 | May 18, 2025 | clinicaltrials |
| NCT01349088 | Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT04418219 | Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Thomas Jefferson UniversityOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT06938711 | A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Context Therapeutics Inc.INDUSTRY | 1 | Apr 22, 2025 | clinicaltrials |
| NCT05940844 | Study of OB-002 in Patients With Refractory Metastatic Cancer | withdrawn | Phase 1 | 0 | Orion Biotechnology Polska Sp. z o.o.INDUSTRY | 0 | Apr 9, 2025 | clinicaltrials |
Data updated 13 days agoSource updated Sep 16, 2026source: clinicaltrials